WebMaravai LifeSciences enables the miracles of science and improves the human condition through its portfolio of market-leading companies and proprietary technologies. … WebJun 29, 2024 · Maravai LifeSciences Holdings, Inc. is a leading life sciences company developing and providing critical products for new drug development, diagnostics, novel …
Who we are — Maravai
WebMaravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. WebNov 19, 2024 · Maravai LifeSciences IPO date is set on November 20, 2024. Maravai specialises in the development of nucleic acids, protein detection reagents and provides biologics safety-testing services. The company’s products and services are used by more than 50,000 customers worldwide, including the top 20 global biopharmaceutical … temra gmbh hamburg
About Us Cygnus Technologies
WebMaravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the ... WebOver a two decade period, advised executives and boards of many of the world's leading pharmaceutical, biotechnology, life sciences tools, diagnostics, managed care and … WebMar 23, 2024 · Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) shares, rose in value on Wednesday, 03/22/23, with the stock price down by -4.02% to the previous day’s close as strong demand from buyers drove the stock to $13.61. Actively observing the price movement in the last trading, the stock closed the ses temra mask